Sector valuations Marker Therapeutics, Inc.
Equities
MRKR
US57055L2060
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.370 USD | -2.84% |
|
0.00% | -8.05% |
| 11-14 | Marker Therapeutics Q3 net loss narrows to $2 mln | RE |
| 11-13 | Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -1.49x | - | 0.07x | - | - | - | - | 23.51M | ||
| 34.13x | 3.56x | 0.54x | 5.07x | 16.98x | 24.87x | 0.99% | 44.92B | ||
| 55.12x | 7.1x | 0.46x | 4.79x | 32.28x | 40.74x | -.--% | 33.88B | ||
| 54.71x | 2.61x | 0.6x | 11.2x | 31.35x | 40.26x | 0.35% | 30.76B | ||
| 20.73x | 3.72x | 3.99x | 2.42x | 10.44x | 15.83x | -.--% | 28.69B | ||
| -12.91x | 17.48x | -0.45x | 336.23x | -10.94x | -10.84x | -.--% | 19.59B | ||
| 45.09x | 166.56x | -0.2x | 8.62x | 27.06x | 35.07x | -.--% | 14.76B | ||
| 27.3x | 13.61x | 2.29x | 4.36x | 19.81x | 20.78x | -.--% | 13.25B | ||
| 20.82x | 2.36x | 0.56x | 1.92x | 8.38x | 12.9x | 1.18% | 13.06B | ||
| -18.71x | -51.47x | -0.27x | 14.6x | -20.35x | -18.74x | -.--% | 12.5B | ||
| -31.84x | 21.44x | -2.38x | 6.11x | 150.38x | -296x | -.--% | 9.1B | ||
| 21.93x | 2.44x | 0.05x | 4.46x | 12.15x | 15.07x | 0.47% | 8.86B | ||
| 21.49x | - | -0.06x | - | - | - | -.--% | 8.24B | ||
| -20.56x | 7.68x | -1.74x | 1172.21x | -17.25x | -17.05x | -.--% | 8.63B | ||
| 42.03x | 3.8x | 0.24x | 6.69x | 18.73x | 20.63x | 0.61% | 8.26B | ||
| -32.2x | 18.46x | -3.18x | 1286.26x | -34.94x | -32.43x | - | 9B | ||
| 16.49x | 0.87x | -0.51x | 1.39x | 7.06x | 7.86x | -.--% | 8.14B | ||
| -22.84x | 6.25x | -63.17x | 142.7x | -16.13x | -14.68x | -.--% | 6.91B | ||
| Average | 12.18x | 14.15x | -3.51x | 188.06x | 14.69x | -9.73x | 0.22% | 15.48B | |
| Weighted average by Cap. | 23.08x | 12.90x | -1.11x | 113.29x | 16.78x | 6.80x | 0.3% |
- Stock Market
- Equities
- MRKR Stock
- Sector Marker Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















